Here are five notes:
1. Artem Kutikov, PhD, will deliver the presentation on the abstract, “Demonstration of a Proof-of-Concept Device for Delivering Bioengineered Neural Stem Cell Trails to the Spinal Cord.”
2. Richard Layer, PhD, Simon Moore, PhD, Alex Aimetti, PhD, Christoph Hofstetter, MD, PhD, James Guest, MD, PhD, and Thomas Ulich, MD, co-authored the paper alongside Dr. Kutikov.
3. InVivo CEO and Chairman Mark Perrin said the abstract illustrates the validation of the TrailMaker, a proof-of-concept device creating longitudinal cellular transplants in the spinal cords of animal models.
4. The TrailMaker is only for preclinical use, right now.
5. Mr. Perrin noted the “prototype device will inform and enable the design of the next-generation device that we hope to study in the clinic in order to help those with chronic spinal cord injuries.”
More articles on devices:
Flexion Therapeutics submits new drug application for knee osteoarthritis pain pill: 4 key notes
Global hip, knee implant market to hit $33B by 2022: 5 observations
SeaSpine names William Rhoda to new executive position: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
